Beranda › PPOK
Uji klinis PPOK yang merekrut di AS
98 studi untuk PPOK merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Philadelphia, PA23 studi
- Miami, FL18 studi
- Birmingham, AL17 studi
- Boston, MA17 studi
- Orlando, FL15 studi
- Houston, TX15 studi
- Baltimore, MD14 studi
- Chicago, IL14 studi
- Pittsburgh, PA12 studi
- Dallas, TX12 studi
- New York City, NY11 studi
- Ann Arbor, MI10 studi
- Detroit, MI9 studi
- Phoenix, AZ9 studi
- Los Angeles, CA9 studi
- Winston-Salem, NC9 studi
- Charlotte, NC9 studi
- Kansas City, KS9 studi
- Columbus, OH8 studi
- Newport Beach, CA8 studi
- Hialeah, FL8 studi
- Cleveland, OH8 studi
- Milwaukee, WI7 studi
- Tampa, FL7 studi
- Nashville, TN7 studi
- Denver, CO7 studi
- Durham, NC7 studi
- Kendall, FL7 studi
- Jacksonville, FL6 studi
- Farmington Hills, MI6 studi
- Aurora, CO6 studi
- Indianapolis, IN6 studi
- West Palm Beach, FL6 studi
- St. Louis, MO5 studi
- Burlington, VT5 studi
- Ocala, FL5 studi
- McKinney, TX5 studi
- Spartanburg, SC5 studi
- Rapid City, SD5 studi
- El Paso, TX5 studi
Berdasarkan negara bagian
- Alabama21 studi
- Arizona17 studi
- California26 studi
- Colorado15 studi
- Connecticut3 studi
- Florida28 studi
- Georgia12 studi
- Idaho4 studi
- Illinois19 studi
- Indiana10 studi
- Iowa6 studi
- Kansas12 studi
- Kentucky5 studi
- Louisiana9 studi
- Maine3 studi
- Maryland16 studi
- Massachusetts25 studi
- Michigan22 studi
- Minnesota11 studi
- Mississippi3 studi
- Missouri7 studi
- Montana3 studi
- Nebraska5 studi
- Nevada8 studi
- New Jersey7 studi
- New York19 studi
- North Carolina22 studi
- Ohio17 studi
- Oklahoma8 studi
- Oregon6 studi
- Pennsylvania33 studi
- South Carolina14 studi
- South Dakota6 studi
- Tennessee14 studi
- Texas25 studi
- Utah6 studi
- Vermont5 studi
- Virginia12 studi
- Washington6 studi
- West Virginia5 studi
- Wisconsin8 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07558265Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
Menerima pesertaFase 2
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07684820Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
Menerima peserta
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05934565A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Menerima pesertaFase 2
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07759245A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
Menerima pesertaFase 2
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07725939A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07780656: Vascular Function in Health and Disease
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT02966665A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Menerima pesertaFase 4
Usia 40 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07190209A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07793409An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Menerima peserta
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Menerima pesertaFase 2
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07646587Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
Menerima pesertaFase 4
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07816835A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07780669Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06603246COPD Exacerbation Follow Up
Menerima pesertaStudi observasional
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07118306The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
Menerima pesertaStudi observasional
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Menerima pesertaFase 2/3
Usia 35 hingga 80 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07363694Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction
Menerima peserta
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT05257681Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07037836Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.